139 related articles for article (PubMed ID: 38058838)
1. IGF2BP3-mediated regulation of
Zhou T; Xiao Z; Lu J; Zhang L; Bo L; Wang J
Am J Cancer Res; 2023; 13(11):5289-5305. PubMed ID: 38058838
[TBL] [Abstract][Full Text] [Related]
2. METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N
Wan W; Ao X; Chen Q; Yu Y; Ao L; Xing W; Guo W; Wu X; Pu C; Hu X; Li Z; Yao M; Luo D; Xu X
Mol Cancer; 2022 Feb; 21(1):60. PubMed ID: 35197058
[TBL] [Abstract][Full Text] [Related]
3. IGF2BP3 promotes glutamine metabolism of endometriosis by interacting with UCA1 to enhances the mRNA stability of GLS1.
Wang H; Cao Y; Gou Y; Wang H; Liang Z; Wu Q; Tan J; Liu J; Li Z; Cui J; Zhang H; Zhang Z
Mol Med; 2024 May; 30(1):64. PubMed ID: 38760723
[TBL] [Abstract][Full Text] [Related]
4. IGF2BP3 enhances lipid metabolism in cervical cancer by upregulating the expression of SCD.
Han C; Hu C; Liu T; Sun Y; Hu F; He Y; Zhang J; Chen J; Ding J; Fan J; Zhang X; Wang J; Qiao X; Jiang D; Yang K; Yang S
Cell Death Dis; 2024 Feb; 15(2):138. PubMed ID: 38355626
[TBL] [Abstract][Full Text] [Related]
5. RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer.
Yang Z; Wang T; Wu D; Min Z; Tan J; Yu B
J Exp Clin Cancer Res; 2020 Sep; 39(1):203. PubMed ID: 32993738
[TBL] [Abstract][Full Text] [Related]
6. IGF2BP3 drives gallbladder cancer progression by m6A-modified CLDN4 and inducing macrophage immunosuppressive polarization.
Qin J; Cui Z; Zhou J; Zhang B; Lu R; Ding Y; Hu H; Cai J
Transl Oncol; 2023 Nov; 37():101764. PubMed ID: 37643553
[TBL] [Abstract][Full Text] [Related]
7. RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent.
Wang X; Tian L; Li Y; Wang J; Yan B; Yang L; Li Q; Zhao R; Liu M; Wang P; Sun Y
J Exp Clin Cancer Res; 2021 Feb; 40(1):80. PubMed ID: 33637103
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of m6A Reader IGF2BP3 Inhibited Hypoxia-Induced Cell Migration and Angiogenesis by Regulating Hypoxia Inducible Factor-1α in Stomach Cancer.
Jiang L; Li Y; He Y; Wei D; Yan L; Wen H
Front Oncol; 2021; 11():711207. PubMed ID: 34621671
[TBL] [Abstract][Full Text] [Related]
9. IGF2BP3 mediates the mRNA degradation of NF1 to promote triple-negative breast cancer progression via an m6A-dependent manner.
Zhang X; Shi L; Sun HD; Wang ZW; Xu F; Wei JF; Ding Q
Clin Transl Med; 2023 Sep; 13(9):e1427. PubMed ID: 37743642
[TBL] [Abstract][Full Text] [Related]
10. Expression pattern analysis of m6A regulators reveals IGF2BP3 as a key modulator in osteoarthritis synovial macrophages.
Lu Y; Zhang H; Pan H; Zhang Z; Zeng H; Xie H; Yin J; Tang W; Lin R; Zeng C; Cai D
J Transl Med; 2023 May; 21(1):339. PubMed ID: 37217897
[TBL] [Abstract][Full Text] [Related]
11. Parkin regulates IGF2BP3 through ubiquitination in the tumourigenesis of cervical cancer.
Sun X; Ye G; Li J; Shou H; Bai G; Zhang J
Clin Transl Med; 2023 Oct; 13(10):e1457. PubMed ID: 37877353
[TBL] [Abstract][Full Text] [Related]
12. Binding of RNA m6A by IGF2BP3 triggers chemoresistance of HCT8 cells via upregulation of ABCB1.
Yang Z; Zhao F; Gu X; Feng L; Xu M; Li T; Liu X; Zhang X
Am J Cancer Res; 2021; 11(4):1428-1445. PubMed ID: 33948366
[TBL] [Abstract][Full Text] [Related]
13. Inhibiting the m
Dai TT; Li YZ; Hu HT; Zhao YM; Peng HY; Bai WD; Wang JW
World J Oncol; 2024 Feb; 15(1):100-113. PubMed ID: 38274714
[TBL] [Abstract][Full Text] [Related]
14. RNA N6-methyladenosine reader IGF2BP3 interacts with MYCN and facilitates neuroblastoma cell proliferation.
Zhu K; Gao T; Wang Z; Zhang L; Tan K; Lv Z
Cell Death Discov; 2023 May; 9(1):151. PubMed ID: 37156775
[TBL] [Abstract][Full Text] [Related]
15. IGF2BP3/HIF1A/YAP signaling plays a role in driving acute-on-chronic liver failure through activating hepatocyte reprogramming.
Cheng K; Liu S; Li C; Zhao Y; Wang Q
Cell Signal; 2023 Aug; 108():110727. PubMed ID: 37257765
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of IGF2BP3 with expression features, prognosis, immune modulation and stemness in hepatocellular carcinoma and pan-cancer.
Qin S; Jin H; Li Y; Chen X; He J; Xiao J; Qin Y; Liu C; Mao Y; Zhao L
J Cancer; 2024; 15(9):2845-2865. PubMed ID: 38577615
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of Yin-Yang-1 Associates with Proliferation and Glutamine Metabolism in Esophageal Carcinoma.
Luo C; Chen X; Bai Y; Xu L; Wang S; Yao L; Guo X; Wang D; Zhong X
Int J Genomics; 2022; 2022():9305081. PubMed ID: 35359580
[TBL] [Abstract][Full Text] [Related]
18. Circ_0001093 promotes glutamine metabolism and cancer progression of esophageal squamous cell carcinoma by targeting miR-579-3p/glutaminase axis.
Qian CJ; Tong YY; Wang YC; Teng XS; Yao J
J Bioenerg Biomembr; 2022 Apr; 54(2):119-134. PubMed ID: 35322289
[TBL] [Abstract][Full Text] [Related]
19. IGF2BP3 promotes adult myocardial regeneration by stabilizing MMP3 mRNA through interaction with m6A modification.
Li S; Shen S; Xu H; Cai S; Yuan X; Wang C; Zhang X; Chen S; Chen J; Shi DL; Zhang L
Cell Death Discov; 2023 May; 9(1):164. PubMed ID: 37188676
[TBL] [Abstract][Full Text] [Related]
20. MYC-activated RNA N6-methyladenosine reader IGF2BP3 promotes cell proliferation and metastasis in nasopharyngeal carcinoma.
Du M; Peng Y; Li Y; Sun W; Zhu H; Wu J; Zong D; Wu L; He X
Cell Death Discov; 2022 Feb; 8(1):53. PubMed ID: 35136045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
